Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

“…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m² per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …”

Mapping changes in patterning after inhibition of Notch activity. by Matthew French (13007466)

“…Note the statistically significant decrease in the CLE and NSB like regions TBX6. …”

Table 3_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Table 4_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Table 1_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Image 3_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Image 1_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Table 2_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.docx by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Image 2_NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy.tif by Serena Cecchetti (396031)

“…In vivo results showed metabolic alterations in SCID mice xenografts after NKEV treatment, associated with a significant reduction of tumor growth (64%). In the in vivo¹H MR spectra we found a significant increase in the tumor lipid/lactate and in taurine signals, both considered as apotosis markers. …”

Image2_Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis.JPEG by Arezoo Mirzaei (11921191)

“…<p>Antimicrobial resistance (AMR) poses a significant global threat to public health systems, rendering antibiotics ineffective in treating infectious diseases. …”

Data Sheet 1_A home-based EEG neurofeedback treatment for chronic neuropathic pain—a pilot study.docx by Mohamed Sakel (9416397)

“…Mood scores showed a significant decrease in depression (p < 0.05), and pain catastrophizing (p < 0.05) scores improved significantly at post-intervention, with continued improvement at the first-month follow-up.…”

Image3_Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis.JPEG by Arezoo Mirzaei (11921191)

“…<p>Antimicrobial resistance (AMR) poses a significant global threat to public health systems, rendering antibiotics ineffective in treating infectious diseases. …”

Table1_Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis.DOCX by Arezoo Mirzaei (11921191)

“…<p>Antimicrobial resistance (AMR) poses a significant global threat to public health systems, rendering antibiotics ineffective in treating infectious diseases. …”